Quantitative reverse transcription PCR revealed that among 52 clinical samples from patients diagnosed with HCC, 46 pairs of tumor tissues showed significant up-regulation of STARD4 mRNA expression, with only 6 pairs showing down-regulation (Fig. 1A). This evidence concerns the gene STARD4 and hepatocellular carcinoma.